News - Boston Scientific EMEA https://news.bostonscientific.eu/ FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints https://news.bostonscientific.eu/2026-05-19-FRACTURE-IDE-trial-of-the-Boston-Scientific-SEISMIQ-TM-4CE-Coronary-Intravascular-Lithotripsy-Catheter-meets-primary-safety-and-effectiveness-endpoints Tue, 19 May 2026 12:31:00 +0200 https://news.bostonscientific.eu/2026-05-19-FRACTURE-IDE-trial-of-the-Boston-Scientific-SEISMIQ-TM-4CE-Coronary-Intravascular-Lithotripsy-Catheter-meets-primary-safety-and-effectiveness-endpoints Data at Heart Rhythm 2026 highlight key Boston Scientific therapies https://news.bostonscientific.eu/2026-04-26-Data-at-Heart-Rhythm-2026-highlight-key-Boston-Scientific-therapies Sun, 26 Apr 2026 19:00:00 +0200 https://news.bostonscientific.eu/2026-04-26-Data-at-Heart-Rhythm-2026-highlight-key-Boston-Scientific-therapies Boston Scientific announces €75 million investment to expand R&D capabilities in Galway https://news.bostonscientific.eu/boston-scientific-announces-75-million-investment-to-expand-rd-capabilities-in-galway Wed, 15 Apr 2026 09:00:00 +0200 https://news.bostonscientific.eu/boston-scientific-announces-75-million-investment-to-expand-rd-capabilities-in-galway CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints https://news.bostonscientific.eu/2026-03-28-CHAMPION-AF-study-of-the-WATCHMAN-FLX-TM-Left-Atrial-Appendage-Closure-Device-as-a-first-line-therapy-for-stroke-risk-reduction-meets-all-primary-and-secondary-safety-and-efficacy-endpoints Sat, 28 Mar 2026 15:55:00 +0100 https://news.bostonscientific.eu/2026-03-28-CHAMPION-AF-study-of-the-WATCHMAN-FLX-TM-Left-Atrial-Appendage-Closure-Device-as-a-first-line-therapy-for-stroke-risk-reduction-meets-all-primary-and-secondary-safety-and-efficacy-endpoints HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism https://news.bostonscientific.eu/2026-03-28-HI-PEITHO-trial-demonstrates-Boston-Scientific-EKOS-TM-Endovascular-System-is-superior-to-standard-of-care-for-treatment-of-acute-pulmonary-embolism Sat, 28 Mar 2026 15:38:00 +0100 https://news.bostonscientific.eu/2026-03-28-HI-PEITHO-trial-demonstrates-Boston-Scientific-EKOS-TM-Endovascular-System-is-superior-to-standard-of-care-for-treatment-of-acute-pulmonary-embolism